Jinyu Medical announced that on January 5, 2026, the 9th meeting of the fourth board of directors of the company deliberated and passed a bill on expected daily related transactions with Jin Qirui in 2026. In 2025, the company expects to trade 240 million yuan with Jin Qirui. A total of 221 million yuan has already been traded from January to November. In 2026, the transaction is expected to be worth 222 million yuan, of which 220 million yuan is expected to be purchased, accounting for no more than 15% of the same business; the provision of labor services is expected to be 1.5 million yuan, accounting for no more than 5% of the same business. Jin Qirui is a wholly-owned subsidiary of Jiajian Company. It has been identified as a related party due to shareholder relationships. Its financial indicators are normal and its ability to perform contracts is good.

Jinyu Medical announced that on January 5, 2026, the 9th meeting of the fourth board of directors of the company deliberated and passed a bill on expected daily related transactions with Jin Qirui in 2026. In 2025, the company expects to trade 240 million yuan with Jin Qirui. A total of 221 million yuan has already been traded from January to November. In 2026, the transaction is expected to be worth 222 million yuan, of which 220 million yuan is expected to be purchased, accounting for no more than 15% of the same business; the provision of labor services is expected to be 1.5 million yuan, accounting for no more than 5% of the same business. Jin Qirui is a wholly-owned subsidiary of Jiajian Company. It has been identified as a related party due to shareholder relationships. Its financial indicators are normal and its ability to perform contracts is good.